Tau protein aggregates are a common pathological feature of Alzheimer's disease and numerous rare neurodegenerative diseases, such as progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD), collectively called tauopathies. Here, MAPT is linked to progressive supranuclear palsy.